IACCGH Business Hour Open Forum

Click Here to View Recording

Article by Somdatta Basu

Title: The Global Impact of Drug Development and the Role of International Collaboration


Houston, TX – In the heart of Houston, amid the towering skyscrapers that define its skyline, Dr. Atul Varadhachary stands tall, bridging the realms of medicine, research, and entrepreneurship. The former President of the Indo-American Chamber of Commerce of Greater Houston (IACCGH) recently shared the profound chapters of his extraordinary life in an illuminating conversation that traversed continents and discipline, on October 28, on the Open Forum as part of the IACCGH Business Hour at the Hum FM Radio studio.

Jagdip Ahluwalia, the Executive Director of IACCGH, hailed Dr. Atul Varadhachary for his contributions to the medical, research, and entrepreneurial spheres. “Dr. Varadhachary is not merely a leader; he is a visionary whose journey exemplifies the excellence in the Indo-American community. His multidimensional impact, spanning medicine, research, and entrepreneurship, makes him an inspiring figure for aspiring individuals across diverse fields,” Ahluwalia affirmed. In the rapidly evolving world of medical science, drug development has become an essential aspect that impacts global health. The process of creating new drugs is a complex and costly endeavor, but it is crucial in addressing various health challenges and improving patient outcomes.

Dr. Atul Varadhachary, managing partner of Fanin Innovation, shared valuable insights on the complexities of drug development during an interview on Open Forum. He emphasized the importance of international collaboration in the drug development process. The narrative seamlessly transitioned to his stint in management consulting at McKinsey and his subsequent foray into the biotech arena. Co-founding Fannin over a decade ago, Dr. Varadhachary found himself at the vanguard of early-stage product development, skillfully navigating the intricate terrain that connects academic research with tangible clinical applications. “In drug development, the journey is labyrinthine, requiring significant time and resources. Balancing innovation with accessibility is a perpetual tightrope walk,” he emphasized, offering a glimpse into the complexities of his entrepreneurial endeavors. The discourse gracefully wove through the dynamics of generic drugs, with Dr. Varadhachary articulating, “Generics aren’t just alternatives; they play a pivotal role in providing cost-effective solutions. Their efficacy often rivals that of branded medications.”Beyond his indelible mark on the pharmaceutical landscape, Dr. Varadhachary’s commitment to community service resonated. As the past President of the IACCGH, he actively champions trade relationships and lends unwavering support to local businesses.

The conversation delved into the personal sphere, acknowledging both the triumphs and tribulations. Dr. Varadhachary’s resilience in the face of adversity echoes not only in the laboratories where groundbreaking research unfolds but also in the hearts touched by the poignant chapters of his life. In Dr.Varadhachary, we find an individual whose journey epitomizes the boundless possibilities that emerge when passion, innovation, and community engagement converge in a symphony of achievement.